1. Home
  2. ABEO vs OIA Comparison

ABEO vs OIA Comparison

Compare ABEO & OIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • OIA
  • Stock Information
  • Founded
  • ABEO N/A
  • OIA 1988
  • Country
  • ABEO United States
  • OIA United States
  • Employees
  • ABEO N/A
  • OIA N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • OIA Finance Companies
  • Sector
  • ABEO Health Care
  • OIA Finance
  • Exchange
  • ABEO Nasdaq
  • OIA Nasdaq
  • Market Cap
  • ABEO 243.9M
  • OIA 287.4M
  • IPO Year
  • ABEO 1980
  • OIA N/A
  • Fundamental
  • Price
  • ABEO $5.19
  • OIA $6.09
  • Analyst Decision
  • ABEO Strong Buy
  • OIA
  • Analyst Count
  • ABEO 3
  • OIA 0
  • Target Price
  • ABEO $18.00
  • OIA N/A
  • AVG Volume (30 Days)
  • ABEO 251.8K
  • OIA 97.9K
  • Earning Date
  • ABEO 11-14-2024
  • OIA 01-01-0001
  • Dividend Yield
  • ABEO N/A
  • OIA 4.88%
  • EPS Growth
  • ABEO N/A
  • OIA N/A
  • EPS
  • ABEO N/A
  • OIA N/A
  • Revenue
  • ABEO N/A
  • OIA N/A
  • Revenue This Year
  • ABEO N/A
  • OIA N/A
  • Revenue Next Year
  • ABEO $15,721.96
  • OIA N/A
  • P/E Ratio
  • ABEO N/A
  • OIA N/A
  • Revenue Growth
  • ABEO 147.52
  • OIA N/A
  • 52 Week Low
  • ABEO $3.05
  • OIA $4.93
  • 52 Week High
  • ABEO $9.01
  • OIA $6.72
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 34.35
  • OIA 49.73
  • Support Level
  • ABEO $5.05
  • OIA $5.90
  • Resistance Level
  • ABEO $5.66
  • OIA $6.01
  • Average True Range (ATR)
  • ABEO 0.27
  • OIA 0.07
  • MACD
  • ABEO -0.06
  • OIA 0.03
  • Stochastic Oscillator
  • ABEO 13.21
  • OIA 93.33

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About OIA Invesco Municipal Income Opportunities Trust

Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.

Share on Social Networks: